亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Treatment outcomes after reduction of the target volume of intensity-modulated radiotherapy following induction chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: A prospective, multi-center, randomized clinical trial

医学 鼻咽癌 B组 放射治疗 A组 诱导化疗 内科学 生活质量(医疗保健) 随机对照试验 单中心 临床试验 顺铂 肿瘤科 化疗 外科 前瞻性队列研究 护理部
作者
Hongru Yang,Xin Chen,Sheng Lin,Jinfeng Rong,Mi Yean Yang,Qinglian Wen,Chang-Ling Shang,Lijia He,Peirong Ren,Shan Xu,Jianwen Zhang,Qiaoli Liu,Haowen Pang,Xiangxiang Shi,Juan Fan,Xiaoyang Sun,Daiyuan Ma,Bangxian Tan,Tao Zhang,Ling Zhang
出处
期刊:Radiotherapy and Oncology [Elsevier BV]
卷期号:126 (1): 37-42 被引量:107
标识
DOI:10.1016/j.radonc.2017.07.020
摘要

To investigate whether reducing the target volume of intensity-modulated radiotherapy (IMRT) after induction chemotherapy (IC) improves the quality of life (QOL) in locoregionally advanced nasopharyngeal carcinoma (NPC) without decreasing the local control and survival rate.A total number of 212 NPC patients staged as III-IVb were randomly assigned to group A (n=97) or group B (n=115) in this prospective clinical trial. All patients received IC followed by cisplatin concurrent with IMRT. IMRT was planned using the images of pre-IC in group A and post-IC in group B.The dose received by normal tissues in group B was lower than that of group A (P<0.05). The recovery of the dry mouth symptoms in group B was significantly improved than group B. The quality of life (QOL) scores in group B were higher than group A. With a median follow-up of 35months, the 1-year estimated overall survival (OS), progression-free survival (PFS), locoregional failure-free survival (LRFFS), distant metastasis-free survival (DMFS) in group A versus group B were 97.9% vs 97.3%, 90.7% vs 92,2%, 99.0% vs 98.2%, 91.8% vs 94.8%. The 2-year OS, PFS, LRFFS, DMFS in group A versus group B were 93.7% vs 92.9%, 83.4% vs 84.3%, 96.8% vs 95.5%, 86.5% vs 89.5%. The 3-year OS, PFS, LRFFS, DMFS in group A versus group B were 82.3% vs 87%, 74.7% vs 83.4%, 91.8 vs 93.9%, 81.3% vs 88.6%, respectively.Reducing the IMRT target volume after IC did not reduce the local control and survival rate in locoregionally advanced NPC but the doses received by normal tissues were decreased, and the QOL scores were improved.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
kkk发布了新的文献求助10
1秒前
SciGPT的应助被大方的猎豹采纳,获得10
3秒前
俊秀的箴完成签到,获得积分10
4秒前
6秒前
pengpengpeng完成签到,获得积分10
21秒前
圆滚滚的大肥猫完成签到 ,获得积分10
22秒前
研友_LwlNdn完成签到,获得积分10
23秒前
乐乐的应助被邓润杰采纳,获得20
24秒前
充电宝的应助被儒雅傲人采纳,获得10
24秒前
Dd关闭了Dd的文献求助
24秒前
26秒前
瘦瘦不乐完成签到,获得积分10
28秒前
lim完成签到,获得积分10
28秒前
漂亮的元灵完成签到,获得积分10
30秒前
31秒前
月亮完成签到 ,获得积分10
32秒前
32秒前
儒雅傲人发布了新的文献求助10
37秒前
Dd完成签到,获得积分10
37秒前
王春梅完成签到 ,获得积分10
39秒前
唠叨的乌完成签到 ,获得积分20
44秒前
赘婿的应助被科研通管家采纳,获得10
48秒前
MchemG的应助被科研通管家采纳,获得30
48秒前
华仔的应助被科研通管家采纳,获得200
48秒前
Nina完成签到,获得积分10
54秒前
sshh123完成签到,获得积分10
54秒前
xiajinjin完成签到,获得积分20
59秒前
糟糕的访波完成签到,获得积分10
1分钟前
酷波er的应助被风趣含双采纳,获得10
1分钟前
1分钟前
手拿把掐发布了新的文献求助30
1分钟前
陌陌完成签到 ,获得积分10
1分钟前
1分钟前
1分钟前
煊陌完成签到 ,获得积分10
1分钟前
伶俐鞋子完成签到,获得积分10
1分钟前
科研通AI6.4的应助被儒雅傲人采纳,获得10
1分钟前
风趣含双发布了新的文献求助10
1分钟前
1分钟前
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8172954
求助须知:如何正确求助?哪些是违规求助? 9565479
关于积分的说明 21780097
捐赠科研通 7764853
什么是DOI,文献DOI怎么找? 3431513
关于科研通互助平台的介绍 2555530
邀请新用户注册赠送积分活动 2476595